[go: up one dir, main page]

WO2002070684A2 - Gene library for screening methods - Google Patents

Gene library for screening methods Download PDF

Info

Publication number
WO2002070684A2
WO2002070684A2 PCT/EP2002/000174 EP0200174W WO02070684A2 WO 2002070684 A2 WO2002070684 A2 WO 2002070684A2 EP 0200174 W EP0200174 W EP 0200174W WO 02070684 A2 WO02070684 A2 WO 02070684A2
Authority
WO
WIPO (PCT)
Prior art keywords
fragments
gene
gene library
genes
library
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2002/000174
Other languages
French (fr)
Other versions
WO2002070684A3 (en
Inventor
Kögl MANFRED
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sygnis Pharma AG
Original Assignee
Lion Bioscience AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lion Bioscience AG filed Critical Lion Bioscience AG
Priority to AU2002249116A priority Critical patent/AU2002249116A1/en
Publication of WO2002070684A2 publication Critical patent/WO2002070684A2/en
Anticipated expiration legal-status Critical
Publication of WO2002070684A3 publication Critical patent/WO2002070684A3/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • C12N15/1055Protein x Protein interaction, e.g. two hybrid selection

Definitions

  • the present invention relates to a method for generating a gene library characterised in that it contains substantially- all genes of a desired source, e.g. organism, in substantially equimolar amounts, wherein each gene is represented by a sufficient amount of different fragments.
  • the present invention also relates to a gene library obtainable by said method.
  • the gene library of the invention is particularly useful for theticianyeast two hybrid" (Y2H) screening.
  • the yeast two hybrid screening technology is based on the screening of gene libraries in order to pick up gene fragments encoding a protein (or protein fragment) which preferably binds to a desired protein.
  • This technology makes use of genetic methods in the yeast Saccharomyces cerevisiae allowing to isolate those fragments contained within a gene library which encode specifically binding proteins.
  • the 2YH screening requires high quality gene libraries.
  • a suitable gene library can be generated by fragmenting genomic DNA and ligating the fragments in suitable vectors.
  • genomic DNA is not suitable for the generation of Y2H libraries due to the presence of large amounts of non-coding regions and introns. Accordingly, one has to switch to cDNA as a basis for the libraries.
  • cDNA based libraries exhibit a variety of disadvantages, e.g.:
  • the cDNA library is restricted to genes which are sufficiently expressed in the tissue used as a source for the mRNA.
  • weakly expressed genes are not present or at least under-represented whereas highly expressed genes are over-represented.
  • the cDNA libraries have to comprise very high amounts of individual clones;
  • genomic DNA was used as template.
  • full length cDNAs found in cDNA libraries can be used as template. Efforts to obtain the complete collection of expressed genes have been initiated in the genome of man (Strausberg et al . , Science 1999 , 286 ( 5439 ) : 455 - 457 ) .
  • the present invention relates to a method for generating a gene library characterised in that it contains substantially all genes of a desired source in substantially equimolar amounts, wherein each gene is represented by a sufficient amount of different fragments, said method comprising
  • the gene library obtainable by this method (which has a much lower complexity compared to a cDNA library) does not contain DNA sequences corresponding to non-coding region or introns, allows to screen all the proteins of a desired organism and does not exhibit the restrictions of gene libraries based on full length genes as regards the possible protein bindings. In addition it allows to determine the region of the protein which is responsible for binding.
  • Starting material for this approach may be the aforementioned collections of expressed genes as templates to generate PCR-products encompassing the open reading frames using specific templates. However, it is equally possible to use reverse-transcribed mRNA from a collection of (human) tissues as a template.
  • the term “weeach gene is represented by a sufficient amount of different fragments” means that the gene is not present in the gene library as a full length gene but in form of fragments altogether representing the entire gene. This means a set of fragments which in their entirety cover the entire sequence of the gene. Preferably, these fragments may be overlapping, such that for each part of the open reading frame at least two or more fragments can be found.
  • the generation of a pool of DNA molecules encoding the full length open reading frames of substantially all genes of the desired source by in vitro amplification, e.g. PCR, wherein the different DNA molecules of the DNA molecules are present in substantially equimolar amounts can be carried by the person skilled in the art by routine methods, e.g. by the methods described in the Example below.
  • First, the sequences of all known open reading frames of a genome are obtained from a publicly available source, such as the Swissprot database.
  • DNA oligonucleotide primers are synthesized which direct the amplification of the open reading frame.
  • primers are then used in separate PCR reactions for each gene using preferably cDNA as template.
  • the fragmentation of the DNA molecules can be carried by a variety of well known methods, e.g sonication, mechanical shearing (e.g. in a syringe) or the use of frequently cutting restriction enzymes.
  • the fragments should have a minimum length of 100 bp. Particularly preferred are fragments having a length in the range of 100 to 1000 bp.
  • the fragmentation of the DNA molecules is random fragmentation, e.g. ultrasonication. Particularly preferred is fragmentation by ultrasonication. Insertion of fragments into a suitable vector requires the polishing of the termini of the fragments prior to cloning. Suitable methods for polishing, i.e. for preparing blunt ends, include treatment with Klenow DNA polymerase or Pwo polymerase.
  • Suitable vectors are for example: pGAD424, pAD-GA 4-2-l, pBD-GAL4, pBD-GAL4 Cam, pCMV-AD, pCMV-BD, pMyr, pSos, pACT2, pAS2-l, pHISi, pLexA, pM, pHISi-1, pB42AD, pVP16, pGADIO, pGBKT7, pLacZi, p8op-lacZ, pAD GH, pGilda, pAD GL, pGADT7, pGBDU, pDBLeu, pPCLeu, pPC86 and pDBTrp.
  • the ligation mixture is transformed in a suitable host, e.g. E. coli, according to methods which are well known to those skilled in the art; see, for example, the techniques described in Maniatis et al . , 1989, Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory.
  • a suitable host e.g. E. coli
  • the vector DNA is isolated from the transformants, purified and introduced into the final host for the expression library, e.g. yeast.
  • yeast a number of vectors containing constitutive or inducible promoters may be used (c.f. above).
  • yeast a number of vectors containing constitutive or inducible promoters may be used (c.f. above).
  • Y2H vectors e.g. pGAD424.
  • Introduction of the above described vectors into the host cell can be effected by well known methods, e.g. calcium phosphate transfection, DEAE-dextran mediated transfection, cationic lipid-mediated transfection, or other methods. Three transfection methods are prefered for yeast: protoplast transformation, lithium acetate mediated transformation and electroporation. Such methods are described in many standard laboratory manuals.
  • the present invention also relates to a gene library characterised in that it contains substantially all genes of a desired source in substantially equimolar amounts, wherein each gene is represented by a sufficient amount of differing fragments and wherein said gene library is obtainable by the method of the invention described above.
  • Uses of such a gene library include Y2H screening.
  • the attBl sites are of use for recombinational cloning of the open reading frame into other vectors and are used to "PCR out" the inserts.
  • PCR products were separated on an 1%-agarose gel and the sizes of the fragments were determined by comparison with comigrating size markers. Subsequently, the gene fragments were purified using the QIAquick PCR purification kit from Qiagen, Hilden (Cat. No. 28106) and the amount of the amplified fragments was determined according to the optical density at 260 run.
  • the molar concentrations of the various purified fragments was determined (taken into account the sizes and the amounts of the fragments) as well as the dilution factor required for ensuring that all PCR products are present in substantially equimolar amounts.
  • the various PCR products were diluted according to the various dilution factors and equal volumina of the diluted solutions were mixed.
  • the PCR products of the mixture were subjected to ultrasonication in such a way that fragments in the range of about 100 to 1000 bp were produced. Sonication was done in a Sonoplus UM20170 (Bandelin, Berlin) instrument for 5 minutes using the following settings: 100%, pulse 0.9, time: 5 min..
  • the fragments obtained were separated on a preparative agarose gel and fragments having the desired sizes were isolated from the gel using the Jetsorb Gel Extraction Kit (Cat. 110300, Genomed, Bad Oeynhausen) .
  • the isolated fragments were pooled, i.e. three pools comprising fragments having lengths of 100 to 300 bp, 300 to 600 bp and 600 to 1000 bp, respectively, were generated.
  • the termini of the sonicated fragments were polished by use of Pwo polymerase (Roche Diagnostics) in a mix containing 300 ng of DNA, 2.5 units of Pwo polymerase, 4.5 ⁇ l of incubation buffer supplied by the manufacturer of the Pwo polymerase (Roche Diagnostics) , 8 ⁇ l of 200 ⁇ M solutions of both desoxyGTP, desoxyATP, desoxyCTP and desoxyTTP, and water to a final volume of 45 ⁇ l for 30 min. at 72°C.
  • Pwo polymerase Roche Diagnostics
  • Y2H-vector (pGAD424) (Clontech, Palo Alto, USA) was linearized using the restriction endonuclease Smal and, subsequently, dephosphorylated using shrimp phosphatase. Each pool of PCR fragments described above was inserted separately into the vector and E. coli (E. coli DH5alpha) were transformed with the ligation mixtures. Subsequently, transformants were plated on LB plates containing ampicillin and the DNA was prepared from the colonies of transformants using the Plasmid Mini Kit from Qiagen, Hilden (Cat. No. 12143) to yield the gene library. In a subsequent experiment, the gene library was used for Y2H screening.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The present invention relates to a method for generating a gene library characterised in that it contains substantially all genes of a desired source in substantially equimolar amounts, wherein each gene is represented by a sufficient amount of different fragments. The present invention also relates to a gene library obtainable by said method. The gene library of the invention is particularly useful for the 'yeast two hybrid' (Y2H) screening.

Description

Gene library for screening methods
The present invention relates to a method for generating a gene library characterised in that it contains substantially- all genes of a desired source, e.g. organism, in substantially equimolar amounts, wherein each gene is represented by a sufficient amount of different fragments. The present invention also relates to a gene library obtainable by said method. The gene library of the invention is particularly useful for the „yeast two hybrid" (Y2H) screening.
The yeast two hybrid screening technology is based on the screening of gene libraries in order to pick up gene fragments encoding a protein (or protein fragment) which preferably binds to a desired protein. This technology makes use of genetic methods in the yeast Saccharomyces cerevisiae allowing to isolate those fragments contained within a gene library which encode specifically binding proteins. However, the 2YH screening requires high quality gene libraries. In the case of organisms having a genome which contains only low amounts of non-coding regions and (almost) no introns (prokaryotes and low eukaryotes) a suitable gene library can be generated by fragmenting genomic DNA and ligating the fragments in suitable vectors. However, in the case of higher eukaryotes genomic DNA is not suitable for the generation of Y2H libraries due to the presence of large amounts of non-coding regions and introns. Accordingly, one has to switch to cDNA as a basis for the libraries. However cDNA based libraries exhibit a variety of disadvantages, e.g.:
- the preparation of cDNA by reverse transcription results in an irregular representation of genes due to the fact that the efficiency of reverse transcription differs depending on various technical features of the mRNA (length, secondary structure etc.) . This applies to random priming as well as to priming using oligo dT primer;
- the cDNA library is restricted to genes which are sufficiently expressed in the tissue used as a source for the mRNA. In other words, in the cDNA library weakly expressed genes are not present or at least under-represented whereas highly expressed genes are over-represented. In order to overcome this problem, i.e. in order to ensure that every gene is present in the library, the cDNA libraries have to comprise very high amounts of individual clones;
- in order to ensure that all genes of an organism are present in the cDNA library different tissues have to be used as sources for the mRNA resulting in an increase of the Y2H screening region by some orders of magnitude .
Due to these limitations Y2H screenings for higher eukaryotes are much more complex compared to Y2H screenings for prokaryotes or lower eukaryotes. Due to this fact the use of this approach in a large scale, e.g. in order to assay all possible protein interactions of a genome (proteoms) is limited. In order to overcome this problem recently several groups have started to clone the open reading frames of all genes of an organism specifically and individually. This can be done by the use of PCR using specific primers to obtain the open reading frame of each gene as a PCR-product. This has been done for the yeast Saccharomyces cerevisiae (Hudson et al., Genome Res. 1997, 7(12): 1169-1173). In this case, genomic DNA was used as template. Alternatively, full length cDNAs found in cDNA libraries can be used as template. Efforts to obtain the complete collection of expressed genes have been initiated in the genome of man (Strausberg et al . , Science 1999 , 286 ( 5439 ) : 455 - 457 ) .
Such collections of full length genes allow Y2H screenings and recently attempts were made to determine all protein interactions within yeast. However, unfortunately, there are lots of interactions which cannot be determined within the full length protein by use of the Y2H system due to the fact that in yeast many foreign proteins, e.g. human proteins, do not exhibit in the correct conformation which is achieved in the natural (physiological) setting, e.g., by posttranslational modifications or the binding of specific ligands. Accordingly, since there is a high probability that the protein expressed in yeast does not exhibit its correct conformation, many of the possible interactions cannot be determined. This is one of the major drawbacks when using full length gene libraries. In addition, this approach does not allow any conclusions as regards the region within the full length protein which is responsible for the binding.
Therefore, it is the object of the present invention to provide a gene library which overcomes the above discussed limitations and failings of the gene libraries of the prior art, i.e. which contains all genes of a desired source in substantially equimolar amounts, wherein each gene is represented by a sufficient amount of different fragments.
According to the invention this is achieved by the subject matters as defined in the claims.
Thus, in one aspect, the present invention relates to a method for generating a gene library characterised in that it contains substantially all genes of a desired source in substantially equimolar amounts, wherein each gene is represented by a sufficient amount of different fragments, said method comprising
(a) generating by in vitro amplification a pool of DNA molecules encoding the full length open reading frames of substantially all genes of the desired source and mixing the different DNA molecules of the pool of DNA molecules in such a way that they are present in substantially equimolar amounts;
(b) fragmentation of the DNA sequences obtained in (a) ; and
(c) cloning of the DNA fragments of (b) into a vector.
The gene library obtainable by this method (which has a much lower complexity compared to a cDNA library) does not contain DNA sequences corresponding to non-coding region or introns, allows to screen all the proteins of a desired organism and does not exhibit the restrictions of gene libraries based on full length genes as regards the possible protein bindings. In addition it allows to determine the region of the protein which is responsible for binding. Starting material for this approach may be the aforementioned collections of expressed genes as templates to generate PCR-products encompassing the open reading frames using specific templates. However, it is equally possible to use reverse-transcribed mRNA from a collection of (human) tissues as a template.
As used herein, the term „each gene is represented by a sufficient amount of different fragments" means that the gene is not present in the gene library as a full length gene but in form of fragments altogether representing the entire gene. This means a set of fragments which in their entirety cover the entire sequence of the gene. Preferably, these fragments may be overlapping, such that for each part of the open reading frame at least two or more fragments can be found.
The generation of a pool of DNA molecules encoding the full length open reading frames of substantially all genes of the desired source by in vitro amplification, e.g. PCR, wherein the different DNA molecules of the DNA molecules are present in substantially equimolar amounts can be carried by the person skilled in the art by routine methods, e.g. by the methods described in the Example below. First, the sequences of all known open reading frames of a genome are obtained from a publicly available source, such as the Swissprot database. In the next step, DNA oligonucleotide primers are synthesized which direct the amplification of the open reading frame.
These primers are then used in separate PCR reactions for each gene using preferably cDNA as template.
The fragmentation of the DNA molecules can be carried by a variety of well known methods, e.g sonication, mechanical shearing (e.g. in a syringe) or the use of frequently cutting restriction enzymes. Preferably, the fragments should have a minimum length of 100 bp. Particularly preferred are fragments having a length in the range of 100 to 1000 bp. In a preferred embodiment, the fragmentation of the DNA molecules is random fragmentation, e.g. ultrasonication. Particularly preferred is fragmentation by ultrasonication. Insertion of fragments into a suitable vector requires the polishing of the termini of the fragments prior to cloning. Suitable methods for polishing, i.e. for preparing blunt ends, include treatment with Klenow DNA polymerase or Pwo polymerase.
Subsequently, the polished fragments are inserted into a vector, preferably a recombinant vector suitable for yeast two hybrid screening. Suitable vectors are for example: pGAD424, pAD-GA 4-2-l, pBD-GAL4, pBD-GAL4 Cam, pCMV-AD, pCMV-BD, pMyr, pSos, pACT2, pAS2-l, pHISi, pLexA, pM, pHISi-1, pB42AD, pVP16, pGADIO, pGBKT7, pLacZi, p8op-lacZ, pAD GH, pGilda, pAD GL, pGADT7, pGBDU, pDBLeu, pPCLeu, pPC86 and pDBTrp. The ligation mixture is transformed in a suitable host, e.g. E. coli, according to methods which are well known to those skilled in the art; see, for example, the techniques described in Maniatis et al . , 1989, Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory. After in vivo amplification, the vector DNA is isolated from the transformants, purified and introduced into the final host for the expression library, e.g. yeast. In yeast, a number of vectors containing constitutive or inducible promoters may be used (c.f. above). For a review see, e.g., Current Protocols in Molecular
Biology, Vol. 2, 1988, Eds. Asubel et al . , Greene Publish Assoc. & Wiley Interscience, Ch. 13; Grant et al . , 1987, Expression and Secretion Vectors for Yeast, in: Methods in Enzymology, Eds. Wu & Grossman, Acad. Press, N.Y., Vol. 153, pp. 516-544. Particulary preferred are Y2H vectors, e.g. pGAD424. Introduction of the above described vectors into the host cell can be effected by well known methods, e.g. calcium phosphate transfection, DEAE-dextran mediated transfection, cationic lipid-mediated transfection, or other methods. Three transfection methods are prefered for yeast: protoplast transformation, lithium acetate mediated transformation and electroporation. Such methods are described in many standard laboratory manuals.
Finally, the present invention also relates to a gene library characterised in that it contains substantially all genes of a desired source in substantially equimolar amounts, wherein each gene is represented by a sufficient amount of differing fragments and wherein said gene library is obtainable by the method of the invention described above. Uses of such a gene library include Y2H screening.
The following example illustrates the invention. Example
Generation of a yeast two hybrid (Y2H) library
The DNA sequences encoding open reading frames (ORF) corresponding to nuclear receptors and cofactors which were inserted in an already available collection of pENTRY-plasmids (RZPD, Heidelberg) were amplified by PCR using the following primers with attBl-sequences (5'-GGG GAC AAG TTT GTA CAA AAA AGC AGG CTC G-3') (SEQ ID NO. 1) and attB2-sequences (5'-GGG GAC CAC TTT GTA CAA GAA AGC TGG GTC-3') (SEQ ID NO. 2) , respectively. The attBl sites are of use for recombinational cloning of the open reading frame into other vectors and are used to "PCR out" the inserts. PCR products were separated on an 1%-agarose gel and the sizes of the fragments were determined by comparison with comigrating size markers. Subsequently, the gene fragments were purified using the QIAquick PCR purification kit from Qiagen, Hilden (Cat. No. 28106) and the amount of the amplified fragments was determined according to the optical density at 260 run. Then, the molar concentrations of the various purified fragments was determined (taken into account the sizes and the amounts of the fragments) as well as the dilution factor required for ensuring that all PCR products are present in substantially equimolar amounts. Then, the various PCR products were diluted according to the various dilution factors and equal volumina of the diluted solutions were mixed. The PCR products of the mixture were subjected to ultrasonication in such a way that fragments in the range of about 100 to 1000 bp were produced. Sonication was done in a Sonoplus UM20170 (Bandelin, Berlin) instrument for 5 minutes using the following settings: 100%, pulse 0.9, time: 5 min.. The fragments obtained were separated on a preparative agarose gel and fragments having the desired sizes were isolated from the gel using the Jetsorb Gel Extraction Kit (Cat. 110300, Genomed, Bad Oeynhausen) . The isolated fragments were pooled, i.e. three pools comprising fragments having lengths of 100 to 300 bp, 300 to 600 bp and 600 to 1000 bp, respectively, were generated. Then, the termini of the sonicated fragments were polished by use of Pwo polymerase (Roche Diagnostics) in a mix containing 300 ng of DNA, 2.5 units of Pwo polymerase, 4.5 μl of incubation buffer supplied by the manufacturer of the Pwo polymerase (Roche Diagnostics) , 8 μl of 200 μM solutions of both desoxyGTP, desoxyATP, desoxyCTP and desoxyTTP, and water to a final volume of 45 μl for 30 min. at 72°C. Y2H-vector (pGAD424) (Clontech, Palo Alto, USA) was linearized using the restriction endonuclease Smal and, subsequently, dephosphorylated using shrimp phosphatase. Each pool of PCR fragments described above was inserted separately into the vector and E. coli (E. coli DH5alpha) were transformed with the ligation mixtures. Subsequently, transformants were plated on LB plates containing ampicillin and the DNA was prepared from the colonies of transformants using the Plasmid Mini Kit from Qiagen, Hilden (Cat. No. 12143) to yield the gene library. In a subsequent experiment, the gene library was used for Y2H screening.

Claims

1. A method for generating a gene library characterised in that it contains substantially all genes of a desired source in substantially equimolar amounts, wherein each gene is represented by a sufficient amount of different fragments, said method comprising
(a) generating by in vitro amplification a pool of DNA molecules encoding the full length open reading frames of substantially all genes of the desired source and mixing the different DNA molecules of the pool of DNA molecules in such a way that they are present in substantially equimolar amounts;
(b) fragmentation of the DNA sequences obtained in (a) ; and (c) inserting the DNA fragments of (b) into a vector.
2. The method of claim 1, wherein the fragmentation is random fragmentation .
3. The method of claim 2, wherein the random fragmentation is achieved by ultrasonication and wherein after ultrasonication the fragments are polished.
4. The method of any one of claims 1 to 3, wherein the fragments have a length in the range of 100 to 1000 bp.
5. The method of any one of claims 1 to 4, wherein the vector of step (c) is a Y2H vector.
6. A gene library characterised in that it contains substantially all genes of a desired source in substantially equimolar amounts, wherein each gene is represented by a sufficient amount of differing fragments and wherein said gene library is obtainable by the method of any one of claims 1 to
7. Use of the gene library of claim 6 for Y2H screening.
PCT/EP2002/000174 2001-01-11 2002-01-10 Gene library for screening methods Ceased WO2002070684A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002249116A AU2002249116A1 (en) 2001-01-11 2002-01-10 Gene library for screening methods

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01100654 2001-01-11
EP01100654.1 2001-01-11

Publications (2)

Publication Number Publication Date
WO2002070684A2 true WO2002070684A2 (en) 2002-09-12
WO2002070684A3 WO2002070684A3 (en) 2003-10-16

Family

ID=8176188

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2002/000174 Ceased WO2002070684A2 (en) 2001-01-11 2002-01-10 Gene library for screening methods

Country Status (2)

Country Link
AU (1) AU2002249116A1 (en)
WO (1) WO2002070684A2 (en)

Cited By (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017044574A1 (en) * 2015-09-11 2017-03-16 Cellular Research, Inc. Methods and compositions for nucleic acid library normalization
US9727810B2 (en) 2015-02-27 2017-08-08 Cellular Research, Inc. Spatially addressable molecular barcoding
US9816137B2 (en) 2009-12-15 2017-11-14 Cellular Research, Inc. Digital counting of individual molecules by stochastic attachment of diverse labels
US9905005B2 (en) 2013-10-07 2018-02-27 Cellular Research, Inc. Methods and systems for digitally counting features on arrays
US10131958B1 (en) 2013-08-28 2018-11-20 Cellular Research, Inc. Massively parallel single cell analysis
US10202641B2 (en) 2016-05-31 2019-02-12 Cellular Research, Inc. Error correction in amplification of samples
US10301677B2 (en) 2016-05-25 2019-05-28 Cellular Research, Inc. Normalization of nucleic acid libraries
US10338066B2 (en) 2016-09-26 2019-07-02 Cellular Research, Inc. Measurement of protein expression using reagents with barcoded oligonucleotide sequences
US10640763B2 (en) 2016-05-31 2020-05-05 Cellular Research, Inc. Molecular indexing of internal sequences
US10669570B2 (en) 2017-06-05 2020-06-02 Becton, Dickinson And Company Sample indexing for single cells
US10697010B2 (en) 2015-02-19 2020-06-30 Becton, Dickinson And Company High-throughput single-cell analysis combining proteomic and genomic information
US10722880B2 (en) 2017-01-13 2020-07-28 Cellular Research, Inc. Hydrophilic coating of fluidic channels
US10822643B2 (en) 2016-05-02 2020-11-03 Cellular Research, Inc. Accurate molecular barcoding
US10941396B2 (en) 2012-02-27 2021-03-09 Becton, Dickinson And Company Compositions and kits for molecular counting
US11124823B2 (en) 2015-06-01 2021-09-21 Becton, Dickinson And Company Methods for RNA quantification
US11164659B2 (en) 2016-11-08 2021-11-02 Becton, Dickinson And Company Methods for expression profile classification
US11319583B2 (en) 2017-02-01 2022-05-03 Becton, Dickinson And Company Selective amplification using blocking oligonucleotides
US11365409B2 (en) 2018-05-03 2022-06-21 Becton, Dickinson And Company Molecular barcoding on opposite transcript ends
US11371076B2 (en) 2019-01-16 2022-06-28 Becton, Dickinson And Company Polymerase chain reaction normalization through primer titration
US11390914B2 (en) 2015-04-23 2022-07-19 Becton, Dickinson And Company Methods and compositions for whole transcriptome amplification
US11397882B2 (en) 2016-05-26 2022-07-26 Becton, Dickinson And Company Molecular label counting adjustment methods
US11492660B2 (en) 2018-12-13 2022-11-08 Becton, Dickinson And Company Selective extension in single cell whole transcriptome analysis
US11535882B2 (en) 2015-03-30 2022-12-27 Becton, Dickinson And Company Methods and compositions for combinatorial barcoding
US11608497B2 (en) 2016-11-08 2023-03-21 Becton, Dickinson And Company Methods for cell label classification
US11639517B2 (en) 2018-10-01 2023-05-02 Becton, Dickinson And Company Determining 5′ transcript sequences
US11649497B2 (en) 2020-01-13 2023-05-16 Becton, Dickinson And Company Methods and compositions for quantitation of proteins and RNA
US11661625B2 (en) 2020-05-14 2023-05-30 Becton, Dickinson And Company Primers for immune repertoire profiling
US11661631B2 (en) 2019-01-23 2023-05-30 Becton, Dickinson And Company Oligonucleotides associated with antibodies
US11739443B2 (en) 2020-11-20 2023-08-29 Becton, Dickinson And Company Profiling of highly expressed and lowly expressed proteins
US11773441B2 (en) 2018-05-03 2023-10-03 Becton, Dickinson And Company High throughput multiomics sample analysis
US11773436B2 (en) 2019-11-08 2023-10-03 Becton, Dickinson And Company Using random priming to obtain full-length V(D)J information for immune repertoire sequencing
US11932849B2 (en) 2018-11-08 2024-03-19 Becton, Dickinson And Company Whole transcriptome analysis of single cells using random priming
US11932901B2 (en) 2020-07-13 2024-03-19 Becton, Dickinson And Company Target enrichment using nucleic acid probes for scRNAseq
US11939622B2 (en) 2019-07-22 2024-03-26 Becton, Dickinson And Company Single cell chromatin immunoprecipitation sequencing assay
US11946095B2 (en) 2017-12-19 2024-04-02 Becton, Dickinson And Company Particles associated with oligonucleotides
US11965208B2 (en) 2019-04-19 2024-04-23 Becton, Dickinson And Company Methods of associating phenotypical data and single cell sequencing data
US12071617B2 (en) 2019-02-14 2024-08-27 Becton, Dickinson And Company Hybrid targeted and whole transcriptome amplification
US12153043B2 (en) 2020-02-25 2024-11-26 Becton, Dickinson And Company Bi-specific probes to enable the use of single-cell samples as single color compensation control
US12157913B2 (en) 2020-06-02 2024-12-03 Becton, Dickinson And Company Oligonucleotides and beads for 5 prime gene expression assay
US12188010B2 (en) 2020-01-29 2025-01-07 Becton, Dickinson And Company Barcoded wells for spatial mapping of single cells through sequencing
US12391940B2 (en) 2020-07-31 2025-08-19 Becton, Dickinson And Company Single cell assay for transposase-accessible chromatin
US12392771B2 (en) 2020-12-15 2025-08-19 Becton, Dickinson And Company Single cell secretome analysis

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5219989A (en) * 1988-12-13 1993-06-15 Mcgill University Bifunctional protein for the isolation of capped mRNA
US5482845A (en) * 1993-09-24 1996-01-09 The Trustees Of Columbia University In The City Of New York Method for construction of normalized cDNA libraries
US20030215798A1 (en) * 1997-06-16 2003-11-20 Diversa Corporation High throughput fluorescence-based screening for novel enzymes
US6399334B1 (en) * 1997-09-24 2002-06-04 Invitrogen Corporation Normalized nucleic acid libraries and methods of production thereof
WO1999067376A1 (en) * 1998-06-25 1999-12-29 Institut Pasteur Exhaustive analysis of viral protein interactions by two-hybrid screens and selection of correctly folded viral interacting polypeptides
WO2000046406A2 (en) * 1999-02-05 2000-08-10 Alphagene, Inc. Arrays for investigating protein protein interactions
WO2000053813A1 (en) * 1999-03-11 2000-09-14 Massachusetts Institute Of Technology Pangenomic libraries

Cited By (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10392661B2 (en) 2009-12-15 2019-08-27 Becton, Dickinson And Company Digital counting of individual molecules by stochastic attachment of diverse labels
US9816137B2 (en) 2009-12-15 2017-11-14 Cellular Research, Inc. Digital counting of individual molecules by stochastic attachment of diverse labels
US9845502B2 (en) 2009-12-15 2017-12-19 Cellular Research, Inc. Digital counting of individual molecules by stochastic attachment of diverse labels
US11970737B2 (en) 2009-12-15 2024-04-30 Becton, Dickinson And Company Digital counting of individual molecules by stochastic attachment of diverse labels
US10047394B2 (en) 2009-12-15 2018-08-14 Cellular Research, Inc. Digital counting of individual molecules by stochastic attachment of diverse labels
US10059991B2 (en) 2009-12-15 2018-08-28 Cellular Research, Inc. Digital counting of individual molecules by stochastic attachment of diverse labels
US11993814B2 (en) 2009-12-15 2024-05-28 Becton, Dickinson And Company Digital counting of individual molecules by stochastic attachment of diverse labels
US12060607B2 (en) 2009-12-15 2024-08-13 Becton, Dickinson And Company Digital counting of individual molecules by stochastic attachment of diverse labels
US10202646B2 (en) 2009-12-15 2019-02-12 Becton, Dickinson And Company Digital counting of individual molecules by stochastic attachment of diverse labels
US10619203B2 (en) 2009-12-15 2020-04-14 Becton, Dickinson And Company Digital counting of individual molecules by stochastic attachment of diverse labels
US11634708B2 (en) 2012-02-27 2023-04-25 Becton, Dickinson And Company Compositions and kits for molecular counting
US10941396B2 (en) 2012-02-27 2021-03-09 Becton, Dickinson And Company Compositions and kits for molecular counting
US10151003B2 (en) 2013-08-28 2018-12-11 Cellular Research, Inc. Massively Parallel single cell analysis
US10927419B2 (en) 2013-08-28 2021-02-23 Becton, Dickinson And Company Massively parallel single cell analysis
US11618929B2 (en) 2013-08-28 2023-04-04 Becton, Dickinson And Company Massively parallel single cell analysis
US10253375B1 (en) 2013-08-28 2019-04-09 Becton, Dickinson And Company Massively parallel single cell analysis
US10208356B1 (en) 2013-08-28 2019-02-19 Becton, Dickinson And Company Massively parallel single cell analysis
US11702706B2 (en) 2013-08-28 2023-07-18 Becton, Dickinson And Company Massively parallel single cell analysis
US10954570B2 (en) 2013-08-28 2021-03-23 Becton, Dickinson And Company Massively parallel single cell analysis
US10131958B1 (en) 2013-08-28 2018-11-20 Cellular Research, Inc. Massively parallel single cell analysis
US9905005B2 (en) 2013-10-07 2018-02-27 Cellular Research, Inc. Methods and systems for digitally counting features on arrays
US12509724B2 (en) 2015-02-19 2025-12-30 Becton, Dickinson And Company High-throughput single-cell analysis combining proteomic and genomic information
US11098358B2 (en) 2015-02-19 2021-08-24 Becton, Dickinson And Company High-throughput single-cell analysis combining proteomic and genomic information
US10697010B2 (en) 2015-02-19 2020-06-30 Becton, Dickinson And Company High-throughput single-cell analysis combining proteomic and genomic information
US9727810B2 (en) 2015-02-27 2017-08-08 Cellular Research, Inc. Spatially addressable molecular barcoding
US10002316B2 (en) 2015-02-27 2018-06-19 Cellular Research, Inc. Spatially addressable molecular barcoding
USRE48913E1 (en) 2015-02-27 2022-02-01 Becton, Dickinson And Company Spatially addressable molecular barcoding
US11535882B2 (en) 2015-03-30 2022-12-27 Becton, Dickinson And Company Methods and compositions for combinatorial barcoding
US11390914B2 (en) 2015-04-23 2022-07-19 Becton, Dickinson And Company Methods and compositions for whole transcriptome amplification
US11124823B2 (en) 2015-06-01 2021-09-21 Becton, Dickinson And Company Methods for RNA quantification
WO2017044574A1 (en) * 2015-09-11 2017-03-16 Cellular Research, Inc. Methods and compositions for nucleic acid library normalization
US10619186B2 (en) 2015-09-11 2020-04-14 Cellular Research, Inc. Methods and compositions for library normalization
US11332776B2 (en) 2015-09-11 2022-05-17 Becton, Dickinson And Company Methods and compositions for library normalization
US10822643B2 (en) 2016-05-02 2020-11-03 Cellular Research, Inc. Accurate molecular barcoding
USRE50636E1 (en) 2016-05-02 2025-10-14 Becton, Dickinson And Company Accurate molecular barcoding
US10301677B2 (en) 2016-05-25 2019-05-28 Cellular Research, Inc. Normalization of nucleic acid libraries
US11397882B2 (en) 2016-05-26 2022-07-26 Becton, Dickinson And Company Molecular label counting adjustment methods
US10640763B2 (en) 2016-05-31 2020-05-05 Cellular Research, Inc. Molecular indexing of internal sequences
US10202641B2 (en) 2016-05-31 2019-02-12 Cellular Research, Inc. Error correction in amplification of samples
US11525157B2 (en) 2016-05-31 2022-12-13 Becton, Dickinson And Company Error correction in amplification of samples
US12331351B2 (en) 2016-05-31 2025-06-17 Becton, Dickinson And Company Error correction in amplification of samples
US11220685B2 (en) 2016-05-31 2022-01-11 Becton, Dickinson And Company Molecular indexing of internal sequences
US11460468B2 (en) 2016-09-26 2022-10-04 Becton, Dickinson And Company Measurement of protein expression using reagents with barcoded oligonucleotide sequences
US11467157B2 (en) 2016-09-26 2022-10-11 Becton, Dickinson And Company Measurement of protein expression using reagents with barcoded oligonucleotide sequences
US11782059B2 (en) 2016-09-26 2023-10-10 Becton, Dickinson And Company Measurement of protein expression using reagents with barcoded oligonucleotide sequences
US10338066B2 (en) 2016-09-26 2019-07-02 Cellular Research, Inc. Measurement of protein expression using reagents with barcoded oligonucleotide sequences
US11608497B2 (en) 2016-11-08 2023-03-21 Becton, Dickinson And Company Methods for cell label classification
US11164659B2 (en) 2016-11-08 2021-11-02 Becton, Dickinson And Company Methods for expression profile classification
US10722880B2 (en) 2017-01-13 2020-07-28 Cellular Research, Inc. Hydrophilic coating of fluidic channels
US11319583B2 (en) 2017-02-01 2022-05-03 Becton, Dickinson And Company Selective amplification using blocking oligonucleotides
US10676779B2 (en) 2017-06-05 2020-06-09 Becton, Dickinson And Company Sample indexing for single cells
US12371729B2 (en) 2017-06-05 2025-07-29 Becton, Dickinson And Company Sample indexing for single cells
US12084712B2 (en) 2017-06-05 2024-09-10 Becton, Dickinson And Company Sample indexing for single cells
US10669570B2 (en) 2017-06-05 2020-06-02 Becton, Dickinson And Company Sample indexing for single cells
US11946095B2 (en) 2017-12-19 2024-04-02 Becton, Dickinson And Company Particles associated with oligonucleotides
US11365409B2 (en) 2018-05-03 2022-06-21 Becton, Dickinson And Company Molecular barcoding on opposite transcript ends
US12421548B2 (en) 2018-05-03 2025-09-23 Becton, Dickinson And Company High throughput multiomics sample analysis
US12421547B2 (en) 2018-05-03 2025-09-23 Becton, Dickinson And Company High throughput multiomics sample analysis
US11773441B2 (en) 2018-05-03 2023-10-03 Becton, Dickinson And Company High throughput multiomics sample analysis
US11639517B2 (en) 2018-10-01 2023-05-02 Becton, Dickinson And Company Determining 5′ transcript sequences
US11932849B2 (en) 2018-11-08 2024-03-19 Becton, Dickinson And Company Whole transcriptome analysis of single cells using random priming
US11492660B2 (en) 2018-12-13 2022-11-08 Becton, Dickinson And Company Selective extension in single cell whole transcriptome analysis
US11371076B2 (en) 2019-01-16 2022-06-28 Becton, Dickinson And Company Polymerase chain reaction normalization through primer titration
US11661631B2 (en) 2019-01-23 2023-05-30 Becton, Dickinson And Company Oligonucleotides associated with antibodies
US12071617B2 (en) 2019-02-14 2024-08-27 Becton, Dickinson And Company Hybrid targeted and whole transcriptome amplification
US11965208B2 (en) 2019-04-19 2024-04-23 Becton, Dickinson And Company Methods of associating phenotypical data and single cell sequencing data
US11939622B2 (en) 2019-07-22 2024-03-26 Becton, Dickinson And Company Single cell chromatin immunoprecipitation sequencing assay
US11773436B2 (en) 2019-11-08 2023-10-03 Becton, Dickinson And Company Using random priming to obtain full-length V(D)J information for immune repertoire sequencing
US11649497B2 (en) 2020-01-13 2023-05-16 Becton, Dickinson And Company Methods and compositions for quantitation of proteins and RNA
US12188010B2 (en) 2020-01-29 2025-01-07 Becton, Dickinson And Company Barcoded wells for spatial mapping of single cells through sequencing
US12153043B2 (en) 2020-02-25 2024-11-26 Becton, Dickinson And Company Bi-specific probes to enable the use of single-cell samples as single color compensation control
US12378594B2 (en) 2020-05-14 2025-08-05 Becton, Dickinson And Company Primers for immune repertoire profiling
US11661625B2 (en) 2020-05-14 2023-05-30 Becton, Dickinson And Company Primers for immune repertoire profiling
US12157913B2 (en) 2020-06-02 2024-12-03 Becton, Dickinson And Company Oligonucleotides and beads for 5 prime gene expression assay
US11932901B2 (en) 2020-07-13 2024-03-19 Becton, Dickinson And Company Target enrichment using nucleic acid probes for scRNAseq
US12391940B2 (en) 2020-07-31 2025-08-19 Becton, Dickinson And Company Single cell assay for transposase-accessible chromatin
US11739443B2 (en) 2020-11-20 2023-08-29 Becton, Dickinson And Company Profiling of highly expressed and lowly expressed proteins
US12392771B2 (en) 2020-12-15 2025-08-19 Becton, Dickinson And Company Single cell secretome analysis

Also Published As

Publication number Publication date
WO2002070684A3 (en) 2003-10-16
AU2002249116A1 (en) 2002-09-19

Similar Documents

Publication Publication Date Title
WO2002070684A2 (en) Gene library for screening methods
Farabaugh et al. A novel programed frameshift expresses the POL3 gene of retrotransposon Ty3 of yeast: frameshifting without tRNA slippage
Pohl et al. EHD2, EHD3, and EHD4 encode novel members of a highly conserved family of EH domain-containing proteins
CN107012164B (en) CRISPR/Cpf1 plant genome directed modification functional unit, vector containing functional unit and application of functional unit
Chenchik et al. Full-length cDNA cloning and determination of mRNA 5′ and 3′ ends by amplification of adaptor-ligated cDNA
US5405775A (en) Retrons coding for hybrid DNA/RNA molecules
MXPA01003643A (en) PRODUCTION OF ssDNA IN VIVO.
KR20170020535A (en) Genome editing using campylobacter jejuni crispr/cas system-derived rgen
Eley et al. A chromosomal region 7p11. 2 transcript map: its development and application to the study of EGFR amplicons in glioblastoma
WO2000056914A1 (en) Method for generating transcriptionally active dna fragments
Küster et al. The nodule-specific VfENOD-GRP3 gene encoding a glycine-rich early nodulin is located on chromosome I of Vicia faba L. and is predominantly expressed in the interzone II-III of root nodules
Fusco et al. In vivo construction of cDNA libraries for use in the yeast two‐hybrid system
Iida et al. Cloning, mapping, genomic organization, and expression of mouse M-LP, a new member of the peroxisomal membrane protein Mpv17 domain family
KR20180128864A (en) Gene editing composition comprising sgRNAs with matched 5' nucleotide and gene editing method using the same
Rutledge et al. Rapid synthesis and cloning of complementary DNA from any RNA molecule into plasmid and phage M13 vectors
KR102541652B1 (en) Safe retroviral vectors developed by insertion of histone or leucine zipper into the viral integrase
US20230048564A1 (en) Crispr-associated transposon systems and methods of using same
Yamamoto et al. Isolation and characterization of a cDNA encoding a high mobility group protein HMG-1 from Canavalia gladiata DC
JPWO2022155055A5 (en)
JP2024522821A (en) Compositions and methods for genome editing
Stranathan et al. Molecular evolution of two actin genes from carrot
Ashworth Two acetyl-CoA acetyltransferase genes located in the t-complex region of mouse chromosome 17 partially overlap the Tcp-1 and Tcp-1 x genes
Nemeroff et al. Construction of full-length cDNA copies of viral double-stranded RNA
KR100762261B1 (en) Full length complementary deoxyribonucleic acid production method and anchors and primers used therein
Shaw et al. Molecular cloning and developmental regulation of Dictyostelium discoideum homologues of the human and yeast HIV1 Tat-binding protein

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP